Journal
/
/
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
DOI:

05:35 min

September 15, 2023

, , , , ,

Chapters

  • 00:00Introduction
  • 00:38Plating of Ovarian Cancer Patient‐Derived Organoids for Viability Assay
  • 02:58Performing Viability Assay Using a Bioluminescence Plate Reader
  • 04:19Results: Effect of Platinum Chemotherapy on Ovarian Cancer Patient‐Derived Organoids
  • 05:17Conclusion

Summary

Automatic Translation

We present a protocol that can be used to conduct therapeutic drug testing with patient-derived ovarian cancer organoids.

Related Videos

Read Article